Evidence map›Paper›PMID 23787488›Full record

ArticleLab on a chip2013

Microfluidics embedded within extracellular matrix to define vascular architectures and pattern diffusive gradients.

Brendon M Baker, Britta Trappmann, Sarah C Stapleton, Esteban Toro, Christopher S Chen

Abstract read
In one paragraph

Article in Lab on a chip, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 73 papers.

0numbers the graph read from it
0cells of the map it votes in
73citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

73 citing papers in PubMed.

  1. Article
  2. Review
  3. Organs on chips: fundamentals, bioengineering and applications.Journal of artificial organs : the official journal of the Japanese Society for Artificial Organs · 2025
    Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Organ-on-a-Chip:Pharmaceutics · 2024
    Article
  10. Article
  11. Article
  12. Use and application of organ-on-a-chip platforms in cancer research.Journal of cell communication and signaling · 2023
    Review
  13. Article
  14. Article
  15. The extracellular matrix mechanics in the vasculature.Nature cardiovascular research · 2023
    Review
  16. Review
  17. Review
  18. In Vitro 3D Modeling of Neurodegenerative Diseases.Bioengineering (Basel, Switzerland) · 2023
    Review
  19. Article
  20. Review

13 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Brendon M BakerTissue Microfabrication Lab, Department of Bioengineering, University of Pennsylvania, Philadelphia, PA 19104, USA.
Britta Trappmann
Sarah C Stapleton
Esteban Toro
Christopher S Chen

Funding

Tissue Chips for Rare Disease: Adding Timothy Syndrome to the HeLIVaSkCa platformUH3EB017103 · NIBIB · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI VUNJAK-NOVAKOVIC, GORDANA · 2014 to 2016
$7.1M
REGULATION OF ANGIOGENESIS BY MICROENVIRONMENTAL CUESR01EB000262 · NIBIB · UNIVERSITY OF PENNSYLVANIA · PI CHEN, CHRISTOPHER S · 2002 to 2023
$6.2M
Engineering Multicellular Tissue Structure, Function, and VascularizationR01EB008396 · NIBIB · UNIVERSITY OF PENNSYLVANIA · PI BHATIA, SANGEETA N., CHEN, CHRISTOPHER S · 2009 to 2018
$5.8M
Training Program in Cancer PharmacologyR25CA101871 · NCI · UNIVERSITY OF PENNSYLVANIA · PI BLAIR, IAN ALEXANDER · 2003 to 2013
$4.3M
Cadherins, integrins, and mechanochemical signalingR01HL073305 · NHLBI · UNIVERSITY OF PENNSYLVANIA · PI CHEN, CHRISTOPHER S · 2003 to 2011
$3.4M
Mesenchymal Stem Cells and the MicroenvironmentR01GM074048 · NIGMS · UNIVERSITY OF PENNSYLVANIA · PI CHEN, CHRISTOPHER S · 2006 to 2013
$2.5M
Integrated heart-liver-vascular systems for drug testing in human health and diseUH2EB017103 · NIBIB · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI VUNJAK-NOVAKOVIC, GORDANA · 2012 to 2013
$1.7M
Howard Hughes Medical InstituteNCI NIH HHS R25 CA101871NCI NIH HHS R25-CA101871-07NHLBI NIH HHS HL73305NHLBI NIH HHS R01 HL073305NIBIB NIH HHS EB00262NIBIB NIH HHS EB08396NIBIB NIH HHS R01 EB000262NIBIB NIH HHS R01 EB008396NIBIB NIH HHS UH2 EB017103NIBIB NIH HHS UH3 EB017103NIGMS NIH HHS GM74048NIGMS NIH HHS R01 GM074048
6 · The paper itself

Abstract

Gradients of diffusive molecules within 3D extracellular matrix (ECM) are essential in guiding many processes such as development, angiogenesis, and cancer. The spatial distribution of factors that guide these processes is complex, dictated by the distribution and architecture of vasculature and presence of surrounding cells, which can serve as sources or sinks of factors. To generate temporally and spatially defined soluble gradients within a 3D cell culture environment, we developed an approach to patterning microfluidically ported microchannels that pass through a 3D ECM. Micromolded networks of sacrificial conduits ensconced within an ECM gel precursor solution are dissolved following ECM gelation to yield functional microfluidic channels. The dimensions and spatial layout of channels are readily dictated using photolithographic methods, and channels are connected to external flow via a gasket that also serves to house the 3D ECM. We demonstrated sustained spatial patterning of diffusive gradients dependent on the architecture of the microfluidic network, as well as the ability to independently populate cells in either the channels or surrounding ECM, enabling the study of 3D morphogenetic processes. To highlight the utility of this approach, we generated model vascular networks by lining the channels with endothelial cells and examined how channel architecture, through its effects on diffusion patterns, can guide the location and morphology of endothelial sprouting from the channels. We show that locations of strongest gradients define positions of angiogenic sprouting, suggesting a mechanism by which angiogenesis is regulated in vivo and a potential means to spatially defining vasculature in tissue engineering applications. This flexible 3D microfluidic approach should have utility in modeling simple tissues and will aid in the screening and identification of soluble factor conditions that drive morphogenetic events such as angiogenesis.

Indexed as

Blood VesselsCell Culture TechniquesDiffusionEquipment DesignExtracellular MatrixHuman Umbilical Vein Endothelial CellsMicrofluidic Analytical TechniquesNeovascularization, PhysiologicTissue Engineering

Identifiers

PMID23787488
PMCPMC4082768

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.